ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $85,000 | -39.7% | 2,111 | -13.9% | 0.00% | -100.0% |
| Q2 2015 | $141,000 | -93.2% | 2,453 | -92.5% | 0.00% | -88.9% |
| Q1 2015 | $2,085,000 | +11.8% | 32,753 | +8.5% | 0.01% | +12.5% |
| Q4 2014 | $1,865,000 | -8.3% | 30,200 | -42.4% | 0.01% | +60.0% |
| Q3 2014 | $2,034,000 | +149.3% | 52,400 | +121.1% | 0.01% | +25.0% |
| Q2 2014 | $816,000 | -27.3% | 23,700 | -8.8% | 0.00% | -20.0% |
| Q1 2014 | $1,123,000 | +5.5% | 26,000 | -2.6% | 0.01% | 0.0% |
| Q4 2013 | $1,064,000 | -12.0% | 26,700 | -17.1% | 0.01% | 0.0% |
| Q3 2013 | $1,209,000 | +97.2% | 32,200 | +41.2% | 0.01% | +66.7% |
| Q2 2013 | $613,000 | – | 22,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |